In one paragraphArticle in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Jose Enrique de la Rubia OrtíDepartment of Basic Biomedical Sciences, Catholic University of Valencia, 46001 Valencia, Spain.ORCID 0000-0001-6808-9505 Jesús PrivadoDepartment of Methodology of Behavioral Sciences, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0003-1511-5129 Rubén Menarques-RamírezNursing Department, Faculty of Health Sciences, University of Alicante, 03690 San Vicente del Raspeig, Spain.
Claudia Emmanuela Sanchis-SanchisDoctoral School, Catholic University of Valencia, 46001 Valencia, Spain.ORCID 0000-0002-2660-5505 Sandra Sancho-CastilloDepartment of Pathology, Catholic University of Valencia, 46001 Valencia, Spain.
Camila Peres RubioInterdisciplinary Laboratory of Clinical Analysis, Regional Campus of International Excellence 'Campus Mare Nostrum', University of Murcia, Espinardo, 30100 Murcia, Spain.ORCID 0000-0002-9293-4147 Luis Pardo-MarinInterdisciplinary Laboratory of Clinical Analysis, Regional Campus of International Excellence 'Campus Mare Nostrum', University of Murcia, Espinardo, 30100 Murcia, Spain.ORCID 0000-0001-5398-1162 María BenllochDepartment of Basic Biomedical Sciences, Catholic University of Valencia, 46001 Valencia, Spain.ORCID 0000-0002-3342-6732 Julio Martín-RuizDepartment of Health and Functional Evaluation, Faculty of Physical Activity and Sports Sciences, Catholic University of Valencia San Vicente Mártir, 46001 Valencia, Spain.ORCID 0000-0001-5089-8427 Funding
Catholic University of Valencia San Vicente Mártir 2021-203-003
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Amyotrophic Lateral SclerosisDietMuscle, SkeletalVitaminsAgedAryldialkylphosphataseBiomarkersButyrylcholinesteraseCross-Sectional StudiesFemaleHumansMaleMiddle AgedMuscle StrengthAryldialkylphosphataseBiomarkersButyrylcholinesterasePON1 protein, humanVitaminsamyotrophic lateral sclerosisbiomarkermuscle activationvitamins
Identifiers
PMID41228417
PMCPMC12608250
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390